Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by N0taP00pon May 30, 2023 12:33pm
302 Views
Post# 35470515

Here's to a successful Canadian investment

Here's to a successful Canadian investment Going by past history, we will get an MD&A soon (tomorrow?). If history repeats, there will be a 100 interpretations on this message board. If TLT has learned their lesson, the MD&A will minimize the need for interpretations on exactly where they are in the process and what to expect, including funding. I don't share the eerie feeling some have that the funding is already figured out. I think it's exactly the opposite. But will be happy if there's no (more) delay and no funding gap. 

Electrameccanica, Sesen Bio, Titan Medical and some rare earth companies, all based in Canada, have been complete disasters for me from an investment perspective.  Theralase gives me some hope for redemption, especially given the stronger collaboration with the US on the science and regulatory approvals.  
<< Previous
Bullboard Posts
Next >>